Abstract
It has been suggested that the heterogeneity of TAAs in lung cancer may affect the therapeutic response and disease progression. Up to now, several tumor-associated antigen (TAA)-based cancer vaccines have been investigated in lung adenocarcinoma (LUAD); however, most of them have failed at the stage of clinical trials. The present study suggests that inter-tumoral heterogeneity of TAAs is large at single-cell resolution, while the communication between tumor cells and infiltrating T cells is closely related to the expression profile of TAAs.
Original language | English |
---|---|
Article number | 41 |
Journal | Biomarker Research |
Volume | 9 |
Issue number | 1 |
DOIs | |
Publication status | Published - Dec 2021 |
Externally published | Yes |
Keywords
- Lung adenocarcinoma
- Single‐cell RNA sequencing
- Tumor associated antigens